Chunlan Huang
Stem Cell Immunity And Regeneration Key Laboratory Of Luzhou
Luzhou, 646000, China
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CCT2 regulates the proliferation, apoptosis, and cell cycle arrest of multiple myeloma cells through the P53 signalling pathway.
Journal: Scientific reports
Published: January 02, 2026
Decreased STING predicts adverse efficacy in bortezomib regimens and poor survival in multiple myeloma.
Journal: Clinical and experimental medicine
Published: November 29, 2024
A Bibliometric Analysis of Immunotherapy in Diffuse Large B-Cell Lymphoma from 2004 to 2024.
Journal: Acta haematologica
Published: June 14, 2024
The efficacy and safety of venetoclax combined with demethylating agents in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis.
Journal: European review for medical and pharmacological sciences
Published: March 18, 2024
18F‑FDG PET/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple myeloma.
Journal: BMC medical imaging
Published: December 29, 2022
The efficacy and safety of triplet regimens based on pomalidomide and dexamethasone for treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis.
Journal: European review for medical and pharmacological sciences
Published: November 17, 2022
Serum metabolomics reveals the effects of accompanying treatment on fatigue in patients with multiple myeloma.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 08, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026